FIELD: medicine.
SUBSTANCE: invention refers to medicine and can be used for correction of A23525T mutation of FTO gene and for evaluation and monitoring of efficiency of complex of health-improving measures in women with excessive body weight with drug-free methods of weight reduction. That is ensured by determining a body weight index, wherein the body weight index of the patient should not exceed 30 kg/m2, age to 50 years. One takes a laxative - Glauber's salt - 35–40 g. For 12–15 days, one does not eat completely. Water is consumed in amount of 1.5–2.0 liters a day. Sleep and rest mode is observed. Daily cleansing enema or hydrocolonotherapy is taken 2–3 times a week. Gradual walking is performed with constant increase of distance from 3 to 6 km a day. Procedures of laser therapy with Milt apparatus on a projection of a spleen with area of 4.2 cm2 infrared laser with wavelength of 0.85–0.89 mcm by a contact method with a beam power of 100 mWt, a radiation power of the main terminal of the laser source of 21 W, pulse repetition frequency of 600 Hz, duration 4 minutes, course 6–8 times of bioresonance therapy in a mode specified by means of interstitial scanner FIS CE 0535 of ESTECK System Complex, USA. One performs body massage the next day. Warm shower is taken 2–3 times a day. Infrared sauna is visited once a week. Every day, 2.0–2.5 hours are taken outdoors. Procedures are accepted accompanied by melodic classical music.
EFFECT: method enables reversing the pathological A23525T of the FTO gene into a normal A23525A genotype by DNA diagnosis of the FTO gene genotype before and after the course.
1 cl, 7 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ACTIVATING AUTOPHAGY IN HUMANS | 2021 |
|
RU2781901C1 |
METHOD FOR PREDICTING DEVELOPMENT OF PERINATAL COMPLICATIONS IN PREGNANT WOMEN AND WOMEN IN LABOR WITH EXCESS WEIGHT OR OBESITY | 2017 |
|
RU2673085C1 |
METHOD OF HUMAN HEALTH IMPROVEMENT | 2017 |
|
RU2656510C1 |
METHOD FOR PREVENTION OF RENAL INSUFFICIENCY IN COMPLEX CORRECTION OF OBESITY PATIENT STATE | 2009 |
|
RU2414253C1 |
METHOD FOR PREDICTING THE GROWTH RATE OF YOUNG CHILDREN | 2018 |
|
RU2672066C1 |
METHOD FOR DETERMINING PREDISPOSITION TO DEVELOPING OBESITY IN CHILDREN IN CONDITIONS OF EXCESSIVE CONTAMINATION WITH ALUMINUM | 2019 |
|
RU2700565C1 |
METHOD OF ESTIMATING RISK OF METABOLIC SYNDROME DEVELOPMENT IN CHILDREN BASING ON GENETIC AND BIOCHEMICAL MARKERS | 2012 |
|
RU2492485C1 |
METHOD OF TREATING AND/OR PREVENTION OF EXCESSIVE BODY WEIGHT AND/OR OBESITY AND/OR METABOLIC DISORDERS | 2008 |
|
RU2403038C2 |
METHOD FOR PREDICTION OF MEN'S RISK OF ESSENTIAL HYPERTENSION ASSOCIATED WITH OBESITY | 2018 |
|
RU2693469C1 |
METHOD FOR PREDICTING THE EFFECTIVENESS OF THERAPY USING ORAL HYPOGLYCEMIC AGENT METFORMIN IN PATIENTS WITH TYPE 2 DIABETES | 2015 |
|
RU2602663C1 |
Authors
Dates
2019-11-22—Published
2018-03-19—Filed